Logo

Veracyte: John Hanna, Morten Frost

Nov 17, 2020

Veracyte has appointed John Hanna as its general manager of endocrinology, breast cancer, and lymphoma; and Morten Frost as its general manager of pulmonology. The firm has established the general manager structure as part of its plans for global expansion.

Hanna currently serves as Veracyte's chief commercial officer. Prior to Veracyte, Frost most recently held the role of head of global marketing for pathology and companion diagnostics at Agilent Technologies.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.